Argentarii LLC Invests $1.89 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Argentarii LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,730 shares of the healthcare conglomerate’s stock, valued at approximately $1,887,000. UnitedHealth Group makes up about 0.9% of Argentarii LLC’s portfolio, making the stock its 27th largest position.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $40,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Stephens upped their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $493.35 on Friday. The company’s fifty day moving average price is $513.78 and its 200-day moving average price is $553.57. The firm has a market capitalization of $451.28 billion, a price-to-earnings ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.